A comprehensive review of adverse events to drugs used in COVID-19 patients: Recent clinical evidence.

Ferreira-da-Silva, Renato; Ribeiro-Vaz, Inês; Morato, Manuela; Junqueira Polónia, Jorge

Ferreira-da-Silva, Renato; Ribeiro-Vaz, Inês; Morato, Manuela; Junqueira Polónia, Jorge.

Afiliación

Ferreira-da-Silva R; Porto Pharmacovigilance Centre, INFARMED, I.P, University of Porto, Porto, Portugal.
Ribeiro-Vaz I; Department of Community Medicine, Health Information and Decision, University of Porto, Porto, Portugal.
Morato M; CINTESIS - Center for Health Technology and Services Research, Porto, Portugal.
Junqueira Polónia J; Porto Pharmacovigilance Centre, INFARMED, I.P, University of Porto, Porto, Portugal.

Eur J Clin Invest ; 52(7): e13763, 2022 Jul.

Article en En | MEDLINE | ID: mdl-35224719

Asunto(s)

Tratamiento Farmacológico de COVID-19; Humanos; Pandemias; Preparaciones Farmacéuticas

Palabras clave

Adverse drug events; Pharmacovigilance; SARS-CoV-2; Therapeutic drug monitoring

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Qualitative_research Límite: Humans Idioma: En Revista: Eur J Clin Invest Año: 2022 Tipo del documento: Article País de afiliación: Portugal

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google